- Home
- ONDS vs BNTC Comparison
ONDS vs BNTC Comparison
Compare ONDS & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONDS
- BNTC
- Stock Information
- Founded
- ONDS 2014
- BNTC 1995
- Country
- ONDS United States
- BNTC United States
- Employees
- ONDS N/A
- BNTC N/A
- Industry
- ONDS Telecommunications Equipment
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- ONDS Telecommunications
- BNTC Health Care
- Exchange
- ONDS Nasdaq
- BNTC Nasdaq
- Market Cap
- ONDS 1.4B
- BNTC 335.5M
- IPO Year
- ONDS N/A
- BNTC N/A
- Fundamental
- Price
- ONDS $5.86
- BNTC $13.24
- Analyst Decision
- ONDS Strong Buy
- BNTC Strong Buy
- Analyst Count
- ONDS 3
- BNTC 5
- Target Price
- ONDS $4.67
- BNTC $26.00
- AVG Volume (30 Days)
- ONDS 49.3M
- BNTC 40.8K
- Earning Date
- ONDS 08-12-2025
- BNTC 09-25-2025
- Dividend Yield
- ONDS N/A
- BNTC N/A
- EPS Growth
- ONDS N/A
- BNTC N/A
- EPS
- ONDS N/A
- BNTC N/A
- Revenue
- ONDS $16,131,404.00
- BNTC N/A
- Revenue This Year
- ONDS $246.94
- BNTC N/A
- Revenue Next Year
- ONDS $161.09
- BNTC N/A
- P/E Ratio
- ONDS N/A
- BNTC N/A
- Revenue Growth
- ONDS 75.16
- BNTC N/A
- 52 Week Low
- ONDS $0.57
- BNTC $8.06
- 52 Week High
- ONDS $6.19
- BNTC $17.15
- Technical
- Relative Strength Index (RSI)
- ONDS 79.19
- BNTC 59.72
- Support Level
- ONDS $3.20
- BNTC $12.57
- Resistance Level
- ONDS $4.33
- BNTC $13.33
- Average True Range (ATR)
- ONDS 0.54
- BNTC 0.60
- MACD
- ONDS 0.17
- BNTC 0.10
- Stochastic Oscillator
- ONDS 89.02
- BNTC 95.59
About ONDS Ondas Holdings Inc.
Ondas Holdings Inc designs, develops, manufactures, sells, and supports FullMAX Software Defined Radio (SDR) technology in the United States, Israel, and India. The company operates in two business segments namely Ondas Networks and Ondas Autonomous Systems. The company generates maximum revenue from Ondas Autonomous Systems through the sales of the Optimus system and separately priced support, maintenance, and ancillary services related to the sale of the Optimus system.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.